Compare PNW & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PNW | PEN |
|---|---|---|
| Founded | 1985 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 12.8B |
| IPO Year | 1994 | 2015 |
| Metric | PNW | PEN |
|---|---|---|
| Price | $105.29 | $316.70 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 15 | 16 |
| Target Price | $100.21 | ★ $360.14 |
| AVG Volume (30 Days) | ★ 1.0M | 363.1K |
| Earning Date | 05-04-2026 | 05-12-2026 |
| Dividend Yield | ★ 3.58% | N/A |
| EPS Growth | N/A | ★ 1155.56 |
| EPS | 0.27 | ★ 0.82 |
| Revenue | ★ $5,339,939,000.00 | $1,403,665,000.00 |
| Revenue This Year | $5.15 | $14.34 |
| Revenue Next Year | $6.89 | $13.71 |
| P/E Ratio | ★ $385.37 | $387.35 |
| Revenue Growth | 4.20 | ★ 17.50 |
| 52 Week Low | $85.32 | $221.26 |
| 52 Week High | $105.08 | $362.41 |
| Indicator | PNW | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 62.95 | 36.97 |
| Support Level | $86.28 | $302.19 |
| Resistance Level | N/A | $322.24 |
| Average True Range (ATR) | 1.96 | 2.44 |
| MACD | 0.28 | -0.00 |
| Stochastic Oscillator | 98.13 | 19.83 |
Pinnacle West is a holding company whose principal subsidiary is Arizona Public Service, a vertically integrated electric utility serving approximately 1.4 million customers across a 35,000-square-mile territory in central Arizona, including the Phoenix area. APS owns or leases 6.5 gigawatts of power generation capacity, including a 29% ownership stake in one of the largest nuclear plants in the US, Palo Verde. Half of the electricity that APS supplies to customers comes from clean energy sources, including nuclear.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.